Regarding the conflicting reports, it is also debatable whether CD44 is significantly associated with a poorer prognosis in many cancers; however, more robust analyses demonstrate that increased CD44 expression has an unlimited correlation with higher histological tumour grade, advanced clinical tumour stage and shorter survival and indicates a poor prognosis. The gene discussed is CD44; the disease is neoplasm.